Diagnosis
Psoriasis
Chronic, non-infectious, inflammatory skin disorder, characterized by well-defined pink scaling plaques.
Etiology
Cause [syb]
Unknown
Genetic predisposition: Familial occurrence, HLA antigens, racial and ethnic groups
Enviromental trigger: Trauma/Koebner phenomenon, infection, hormone, sunlight, tobacco, alcohol, emotion, drugs (chloroquine, lithium, beta-blockers, steroids, and NSAIDs), tobacco, alcohol, emotion)
Pathogenesis [syb]
Autoimmune disease mediated by T lymphocytes
Dermal infiltration of activated T cells --> stimulate the proliferation of keratinocytes
Dysregulation in keratinocyte turnover:
Epidermal hyperplasia
Parakeratosis
Cells fail to secrete lipids --> formation of thick plaques
These factors induce each other, leading to a vicious cycle of keratinocyte proliferation and inflammatory reaction
Classification:
Type 1 psoriasis: Positive family history, before age 40, associated with HLA-Cw6
Type 2 psoriasis: No family history, after age 40, not associated with HLA-Cw6
Typical clinical manifestation:
Lesions: Well-defined erythematous plaques covered with silvery scales
Localization: scalp, extensors of knees/elbows, and lumbosacral region
Types of psoriasis [nov]
Chronic stationary psoriasis (psoriasis vulgaris): Most common
scalp, extensor surfaces, genitals, umbilicus, and lumbosacral and retroauricular
Plaque psoriasis: Extensor surfaces of the knees, elbows, scalp, and trunk
Guttate psoriasis: Trunk; 2-3 weeks after an upper respiratory tract infection with group A beta-hemolytic streptococci
Inverse psoriasis: flexural surfaces, armpit, and groin; under the breast; and in the skin folds (often misdiagnosed as a fungal infection)
Pustular psoriasis: palms and soles or diffusely over the body
Erythrodermic psoriasis: erythema of the entire body surface
Scalp psoriasis
Nail psoriasis: may lead to onychomycosis
Psoriatic arthritis: usually in the hands and feet and, occasionally, the large joints
Oral psoriasis: cheilosis
Eruptive psoriasis: upper trunk and upper extremities
Napkin psoriasis: diaper region
Linear psoriasis: within a dermatome
Ocular: Ectropion, trichiasis, conjunctivitis, conjunctival hyperemia, keratitis, blepharitis
Complications [syb]
Secondary infections
Poor cosmesis
Psoriatic arthritis
Ocular manifestations
Risk of lymphoma
Increased risk of adverse cardiac events
Epidemiology
Incidence per 100.000 [1be][noe][24u][py9][rfm][aie][n1y][adg][8b6][a8u]
Prevalence per 100.000 [1be][noe][24u][py9][rfm][aie][n1y][adg][8b6][a8u]
Symptoms & findings
Symptoms
Arthralgia, Arthritis, Blepharitis, Conjunctivitis, Fever, Koebner phenomenon, Malaise, Nail pitting, Onycholysis, Pruritus, Subungal hyperkeratosis, Xeroderma
Clinical findings
Anamneses
None listed.
Localized findings
Approach
Blood test: WBC, creatinine, liver function tests, hepatitis, tuberculosis, HIV, hCG, rheumatoid factor (negative), uric acid (elevated)
Biopsy
Throat swab
Fluid from pustules
Nail microscopy
X-ray
Rheumatoid factor
Treatment
Nondrug therapy:
Phototherapy: Combines psoralen with exposure to ultraviolet light
Stress reduction
Sunshine, sea bathing, moisturizers, oatmeal baths
Punctal occlusion (and ocular lubricants): For keratoconjunctivitis sicca
Bandage contact lens: To retard corneal melting
Pharmacotherapy
Topical corticosteroids: betamethasone 0.025-0.1% cream [nov]
Topical aryl hydrocarbon receptor (AhR) agonists
Ophthalmic corticosteroids
Intramuscular corticosteroids
Intralesional corticosteroids: resistant plaques and psoriatic nails
Coal tar 0.5-33%
Keratolytic agents (anthralin, urea): facilitate direct steroid contact with the skin
Vitamin D analogs (calcitriol ointment)
Topical retinoids
Antimetabolites (methotrexate)
Immunomodulators (tacrolimus topical 0.1%, cyclosporine, alefacept, ustekinumab)
Tumor necrosis factor (TNF) inhibitors (infliximab, etanercept, adalimumab)
Phosphodiesterase-4 inhibitors (apremilast, roflumilast topical)
Interleukin inhibitors
Artificial tears
Differential diagnoses
Conjunctivitis, Contact dermatitis, Cutaneous T-cell lymphoma, Eczema, Gout, Keratitis, Lichen planus, Lichen simplex chronicus, Mycosis fungoides, Onychomycosis, Pityriasis alba, Pityriasis rosea, Pseudogout, Psoriatic arthritis, Reactive arthritis, Rheumatoid arthritis, Seborrheic dermatitis, Squamous cell carcinoma, Syphilis, Tinea corporis, Tinea unguium
References
[1] Nair PA, Badri T. Psoriasis. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448194/
[2] https://emedicine.medscape.com/article/1943419
[3] Zhang Y, Dong S, Ma Y, Mou Y. Burden of psoriasis in young adults worldwide from the global burden of disease study 2019. Front Endocrinol (Lausanne). 2024 Feb 13;15:1308822.
[4] Dairov A, Issabekova A, Sekenova A, Shakhatbayev M, Ogay V. Prevalence, Incidence, Gender and Age Distribution, and Economic Burden of Psoriasis Worldwide and in Kazakhstan. J CLIN MED KAZ. 2024;21(2):18-30.
[5] Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, Guo C, Dellavalle R, Grada A, Wong P, La Vecchia C, Tam LS, Cooper KD, Naghavi M. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front Med (Lausanne). 2021 Dec 16;8:743180.
[6] Deike M, Wang J, Brinks R, Meller S, Ocker L, Bechara FG, Distler JHW, Baraliakos X, Kiefer D, Sewerin P. Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Arch Dermatol Res. 2024 Jan 4;316(2):65.
[7] Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009 Mar;60(3):394-401.
[8] Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013 Feb;133(2):377-85.
[9] Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010 Jun;62(6):979-87.
[10] Burshtein J, Strunk A, Garg A. Incidence of psoriasis among adults in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2021 Apr;84(4):1023-1029.
[11] Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and Prevalence of Psoriasis in Denmark. Acta Derm Venereol. 2017 Jul 6;97(7):808-812.
[12] Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol. 2021 Jan;84(1):46-52.
[13] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]
[14] Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021 Feb;184(2):243-258.